O. Moe

The Lancet · 2006–2017

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Who trusts O. Moe overall

  1. T. Alelign

Papers from O. Moe's perspective

Ordered by how strongly the researchers O. Moe trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  2. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
  3. Guidelines for investigating causality of sequence variants in human disease
  4. The support of human genetic evidence for approved drug indications (Nature Genetics)
  5. Worldwide access to treatment for end-stage kidney disease: a systematic review. (The Lancet)
  6. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  7. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. (The Lancet)
  8. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
  9. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis (PLoS ONE)
  10. Genetic Misdiagnoses and the Potential for Health Disparities

Their papers